<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <Volume-Issue>Volume 4; Issue 1</Volume-Issue>
      <Season>(Jan-Feb, 2023)</Season>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Pheochromocytoma: A Great Simulator. Small Series of A Single Institution</ArticleTitle>
      <Abstract>Background: pheochromocytoma is a catecholamine-secreting neuroendocrine tumor, with usual origin in the adrenal medulla. They are mostly diagnosed as adrenal incidentalomas in abdominal tomography (CT) or magnetic resonance imaging (MRI) or by related symptoms, as the classic triad including headaches, profuse sweating, and palpitations. Although it is a rare cause of secondary hypertension, this occurs in a great proportion of patients and it is usually sustained and paroxysmal. The biochemical diagnosis requires the dosage of plasmatic and/or urinary metanephrines and once confirmed, an imaging study such as CT or MRI must be requested to determine its location. Pheochromocytoma usually has low metastatic potential; treatment is adrenalectomy, conventional or laparoscopic, and resection can be curative. The reason for presenting these cases is to show two forms of presentation of a rare disease, with normal or hypertension, even in large tumors.&#13;
Cases: We present four cases of Pheochromocytoma, two of which were diagnosed due to secondary hypertension and two as adrenal incidentalomas. In two of them the concomitant diagnosis of panic attacks and anxiety attacks was made, which sometimes shares clinical symptoms with the clinical picture of catecholamine’s excess.&#13;
A 31-year-old man presents who presented with resistant hypertension and paroxysmal adrenergic crisis.&#13;
A 46-year-old woman who presented with hypertension difficult to treat and adrenal incidentaloma.&#13;
A 35-year-old woman who had big adrenal incidentaloma and normal blood pressure.&#13;
A 34-year-old woman developed panic attacks and was found an adrenal incidentaloma on CT without hypertension.&#13;
Conclusion: pheochromocytoma is a rare tumor that can have variable clinical presentations, with low malignant potential in the majority of the cases, and its accurate treatment relays on the clinical suspicion of this entity.</Abstract>
      <Keywords>Pheochromocytoma,Adrenal Tumor,Secondary Hypertension,Cases Series</Keywords>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=14309&amp;title=Pheochromocytoma: A Great Simulator. Small Series of A Single Institution</Abstract>
        <References>Ahmed MB, Sami ZA, Razzaq F, Ali MA, Fazal A, Iftikhar A. Pheochromocytoma: An Incidental Finding in an Asymptomatic Older Adult with Renal Oncocytoma. Fed Pract 2021; 38: e81-e85.&#13;
Calissendorff J, Juhlin CC, Bancos I, Falhammar H. Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance. Cancers (Basel) 2022; 14: 917.&#13;
Eisenhofer G, Klink B, Richter S, Lenders JW, Robledo M. Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing. Clin Biochem Rev 2017; 38: 69-100.&#13;
Eisenhofer G, Prejbisz A, Peitzsch M, Pamporaki C, Masjkur J, Rogowski-Lehmann N, Langton K, Tsourdi E, Peczkowska M, Fliedner S, Deutschbein T, Megerle F, Timmers HJLM, Sinnott R, Beuschlein F, Fassnacht M, Januszewicz A, Lenders JWM. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites. Clin Chem 2018; 64: 1646-1656.&#13;
Geroula A, Deutschbein T, Langton K, Masjkur J, Pamporaki C, Peitzsch M, Fliedner S, Timmers HJLM, Bornstein SR, Beuschlein F, Stell A, Januszewicz A, Prejbisz A, Fassnacht M, Lenders JWM, Eisenhofer G. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. Eur J Endocrinol 2019; 181: 409-420.&#13;
Gruber LM, Hartman RP, Thompson GB, McKenzie TJ, Lyden ML, Dy BM, Young WF, Bancos I. Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery. J Clin Endocrinol Metab 2019; 104: 1386-1393.&#13;
Kenny L, Rizzo V, Trevis J, Assimakopoulou E, Timon D. The unexpected diagnosis of phaeochromocytoma in the anaesthetic room. Ann Card Anaesth 2018; 21: 307-310.&#13;
Kim JH, Moon H, Noh J, Lee J, Kim SG. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service. Endocrinol Metab (Seoul) 2020; 35: 157-164.&#13;
Lenders J, Kerstens M, Amard L, Prejbisz A, Robledo M. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 2020; 38: 1443-1456.&#13;
Mintegui G, Mendoza B, Guarneri C. Normotensive pheochromocytoma associated with ganglioneuroma. Med Clin (Barc) 2022; 158: 43-44.&#13;
Moor R, Goutnik M, Lucke-Wold B, Laurent D, Chen S, Friedman W, Rahman M, Allen N, Rivera-Zengotita M, Koch M. Clival Paraganglioma, Case Report and Literature Review. OBM Neurobiol 2022; 6: 13.&#13;
Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers HJLM, Fassnacht M, Klink B, Lodish M, Stratakis CA, Huebner A, Fliedner S, Robledo M, Sinnott RO, Januszewicz A, Pacak K, Eisenhofer G. Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas. J Clin Endocrinol Metab 2017; 102: 1122-1132.&#13;
Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 2016; 174: G1-G10.&#13;
Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002; 26: 551-566.&#13;
Thompson LDR, Gill AJ, Asa SL, Clifton-Bligh RJ, de Krijger RR, Kimura N, Komminoth P, Lack EE, Lenders JWM, Lloyd RV, Papathomas TG, Sadow PM, Tischler AS. Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol 2021; 110: 83-97.&#13;
Young W, Nieman L, Martin K. Clinical presentation and diagnosis of pheochromocytoma. Up-to-date: accessed December 21, 2022. Available at: https://www.medilib.ir/uptodate/show/130</References>